SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sarah Cargnin, Chiara Pautasso, Michele Viana, Grazia Sances, Daniela Mittino, Roberto Cantello, Cristina Tassorelli, Giuseppe Nappi, Salvatore Terrazzino, Association of RAMP1 rs7590387 With the Risk of Migraine Transformation Into Medication Overuse Headache, Headache: The Journal of Head and Face Pain, 2015, 55, 5
  2. 2
    Lars Edvinsson, CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment, British Journal of Clinical Pharmacology, 2015, 79, 6
  3. 3
    Gang Yao, Ximei Han, Tingting Hao, Qian Huang, Tingmin Yu, Effects of rizatriptan on the expression of calcitonin gene-related peptide and cholecystokinin in the periaqueductal gray of a rat migraine model, Neuroscience Letters, 2015, 587, 29

    CrossRef

  4. 4
    Xiao-ping Cui, Jian-xin Ye, Hang Lin, Jun-shan Mu, Min Lin, Efficacy, Safety, and Tolerability of Telcagepant in the Treatment of Acute Migraine: A meta-Analysis, Pain Practice, 2015, 15, 2
  5. 5
    János Tajti, Délia Szok, Zsófia Majláth, Bernadett Tuka, Anett Csáti, László Vécsei, Migraine and neuropeptides, Neuropeptides, 2015,

    CrossRef

  6. 6
    Roger Cady, Ira Turner, Kent Dexter, M. E. Beach, Ryan Cady, Paul Durham, An Exploratory Study of Salivary Calcitonin Gene-Related Peptide Levels Relative to Acute Interventions and Preventative Treatment With OnabotulinumtoxinA in Chronic Migraine, Headache: The Journal of Head and Face Pain, 2014, 54, 2
  7. 7
    Stephen J. Peroutka, Calcitonin Gene-Related Peptide Targeted Immunotherapy for Migraine: Progress and Challenges in Treating Headache, BioDrugs, 2014, 28, 3, 237

    CrossRef

  8. 8
    Khatera Ibrahimi, Emile G.M. Couturier, Antoinette MaassenVanDenBrink, Migraine and perimenopause, Maturitas, 2014, 78, 4, 277

    CrossRef

  9. You have free access to this content9
    S Benemei, C Fusi, Gabriela Trevisan, Pierangelo Geppetti, The TRPA1 channel in migraine mechanism and treatment, British Journal of Pharmacology, 2014, 171, 10
  10. 10
    Paul Durham, Spyros Papapetropoulos, Biomarkers Associated With Migraine and Their Potential Role in Migraine Management, Headache: The Journal of Head and Face Pain, 2013, 53, 8
  11. 11
    Per G. Djupesland, John C. Messina, Ramy A. Mahmoud, Breath Powered Nasal Delivery: A New Route to Rapid Headache Relief, Headache: The Journal of Head and Face Pain, 2013, 53,
  12. 12
    Eric A. Kaiser, Andrew F. Russo, CGRP and migraine: Could PACAP play a role too?, Neuropeptides, 2013, 47, 6, 451

    CrossRef

  13. You have free access to this content13
    C S Walker, D L Hay, CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?, British Journal of Pharmacology, 2013, 170, 7
  14. 14
    Paul L. Durham, Caleb G. Masterson, Two Mechanisms Involved in Trigeminal CGRP Release: Implications for Migraine Treatment, Headache: The Journal of Head and Face Pain, 2013, 53, 1
  15. 15
    Andrea Negro, Luana Lionetto, Maurizio Simmaco, Paolo Martelletti, CGRP receptor antagonists: an expanding drug class for acute migraine?, Expert Opinion on Investigational Drugs, 2012, 21, 6, 807

    CrossRef

  16. You have free access to this content16
    AJ McNeish, BT Roux, S-B Aylett, AM Van Den Brink, GS Cottrell, Endosomal proteolysis regulates calcitonin gene-related peptide responses in mesenteric arteries, British Journal of Pharmacology, 2012, 167, 8
  17. 17
    Ann C. Raddant, Andrew F. Russo, Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation, Expert Reviews in Molecular Medicine, 2011, 13,

    CrossRef

  18. 18
    Saurabh Gupta, Stephanie J. Nahas, B. Lee Peterlin, Chemical Mediators of Migraine: Preclinical and Clinical Observations, Headache: The Journal of Head and Face Pain, 2011, 51, 6
  19. You have free access to this content19
    Peer C. Tfelt-Hansen, Peter J. Koehler, One Hundred Years of Migraine Research: Major Clinical and Scientific Observations From 1910 to 2010, Headache: The Journal of Head and Face Pain, 2011, 51, 5
  20. 20
    Anna Ferrari, Ilaria Tiraferri, Laura Neri, Emilio Sternieri, Why pharmacokinetic differences among oral triptans have little clinical importance: a comment, The Journal of Headache and Pain, 2011, 12, 1, 5

    CrossRef

  21. 21
    Paul L. Durham, Carrie V. Vause, Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine, CNS Drugs, 2010, 24, 7, 539

    CrossRef

  22. 22
    Paul L. Durham, Carrie V. Vause, Frederick Derosier, Susan McDonald, Roger Cady, Vincent Martin, Changes in Salivary Prostaglandin Levels During Menstrual Migraine With Associated Dysmenorrhea, Headache: The Journal of Head and Face Pain, 2010, 50, 5
  23. 23
    Stephen D. Silberstein, Meeting acute migraine treatment needs through novel treatment formulations, Neurotherapeutics, 2010, 7, 2, 153

    CrossRef

  24. 24
    Lars Edvinsson, Mattias Linde, New drugs in migraine treatment and prophylaxis: telcagepant and topiramate, The Lancet, 2010, 376, 9741, 645

    CrossRef

  25. 25
    Saurabh Gupta, Carlos M. Villalón, The relevance of preclinical research models for the development of antimigraine drugs: Focus on 5-HT1B/1D and CGRP receptors, Pharmacology & Therapeutics, 2010, 128, 1, 170

    CrossRef